在减肥药热潮期间，Hims & Hers最近的消息引来了大家的广泛关注。这个曾因销售平价仿制减肥药而一度风头劲劲的远程医疗平台，再次推出了三款新药物，成功刺激了其股价在短短一天之内上涨了5%！你是不是也在好奇，究竟发生了什么？

Investing.com — Hims & Hers Health, Inc. (NYSE:HIMS)的高管Irene Becklund最近出售了公司股票，根据向美国证券交易委员会提交的文件显示。4月3日，Becklund以每股28.78美元的价格出售了2,203股A类普通股，交易总价值为63,402美元。此次出售后，Becklund直接持有8,007股。该交易是根据2024年8月7日采用的规则 ...

近年来，全球对于健康与美的追求日益明显，减肥药物的市场需求持续上升。在这个热潮中，平价减肥药供应商Hims & Hers Health Inc.的最新举动引发了市场的广泛关注。近日，该公司的股价在单日内飙升14%，原因正是其宣布与礼来制药展开战略合作，计划销售后者的减肥药产品Zepbound。本文将深入分析Hims & Hers的公司背景、Zepbound的药物信息、医药行业现状以及此合作对市场的 ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

Investing.com — Hims & Hers Health, Inc. (NYSE:HIMS)的首席会计官Becklund Irene近期减持了其在公司的部分股份。根据最近的SEC文件显示，Irene以每股28.78美元的价格出售了2,203股A类普通股，交易总额为63,402美元。 此次出售后，Irene直接持有8,007股股份。此次交易是根据2024年8月7日采用的Rule 10b5 ...

Investors worry patients won’t make that price leap and that Hims, which has built its business on affordable healthcare, ...

Shares of Hims & Hers Health ( HIMS 5.01%) surged on Tuesday, closing the session up 5.25% after having been up by as much as ...

Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025.

周二，美股远程医疗公司Hims & Hers ...

Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...

Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co. Zepbound and generic ...